Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
868
-3.86%
|
$211,792
$244.77 P/Share
|
|
Feb 15
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
1,749
+7.21%
|
-
|
|
Feb 15
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-8.55%
|
$39,284
$244.77 P/Share
|
|
Feb 15
2023
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
393
+17.27%
|
-
|
|
Feb 15
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
625
-30.11%
|
$152,500
$244.77 P/Share
|
|
Feb 15
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,749
+45.73%
|
-
|
|
Feb 15
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
666
-7.4%
|
$162,504
$244.77 P/Share
|
|
Feb 15
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
2,124
+19.09%
|
-
|
|
Feb 15
2023
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-6.43%
|
$66,612
$244.77 P/Share
|
|
Feb 15
2023
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
723
+14.54%
|
-
|
|
Feb 15
2023
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,308
-4.84%
|
$319,152
$244.77 P/Share
|
|
Feb 15
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+12.18%
|
-
|
|
Feb 15
2023
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,116
-0.87%
|
$272,304
$244.77 P/Share
|
|
Feb 15
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+1.73%
|
-
|
|
Feb 15
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-2.22%
|
$100,772
$244.77 P/Share
|
|
Feb 15
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,311
+6.59%
|
-
|
|
Feb 13
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
33,249
-61.57%
|
$8,146,005
$245.61 P/Share
|
|
Feb 13
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
54,000
+50.0%
|
$3,402,000
$63.25 P/Share
|
|
Feb 13
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
1,307
-46.75%
|
$321,522
$246.09 P/Share
|
|
Feb 10
2023
|
Michele Di Martino Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
776
-18.75%
|
$190,120
$245.27 P/Share
|
|
Feb 10
2023
|
Michele Di Martino Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,491
+36.61%
|
-
|
|
Feb 06
2023
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
45,025
-26.42%
|
$11,256,250
$250.53 P/Share
|
|
Feb 06
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
54,000
+24.06%
|
$3,402,000
$63.25 P/Share
|
|
Jan 27
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,629
-10.74%
|
$407,250
$250.0 P/Share
|
|
Jan 27
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,629
+9.7%
|
$289,962
$178.85 P/Share
|
|
Dec 15
2022
|
David J. Rosa President |
SELL
Bona fide gift
|
Direct |
642
-0.55%
|
-
|
|
Nov 08
2022
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
6,375
-36.22%
|
$1,523,625
$239.36 P/Share
|
|
Nov 08
2022
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
6,375
+26.59%
|
$337,875
$53.76 P/Share
|
|
Nov 01
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,000
-93.36%
|
$2,000,000
$250.06 P/Share
|
|
Nov 01
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+48.27%
|
$1,360,000
$170.44 P/Share
|
|
Oct 21
2022
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
44,203
-65.49%
|
$9,282,630
$210.84 P/Share
|
|
Oct 21
2022
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
67,500
+50.0%
|
$4,252,500
$63.25 P/Share
|
|
Oct 21
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,000
-93.36%
|
$1,672,000
$209.78 P/Share
|
|
Oct 21
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+48.27%
|
$1,360,000
$170.44 P/Share
|
|
Sep 08
2022
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
6,375
-36.22%
|
$1,338,750
$210.76 P/Share
|
|
Sep 08
2022
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
6,375
+26.59%
|
$337,875
$53.76 P/Share
|
|
Aug 15
2022
|
Amy L Ladd Director |
SELL
Open market or private sale
|
Direct |
600
-45.45%
|
$142,200
$237.03 P/Share
|
|
Aug 03
2022
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
6,375
-36.22%
|
$1,517,250
$238.04 P/Share
|
|
Aug 03
2022
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
6,375
+26.59%
|
$337,875
$53.76 P/Share
|
|
Jul 27
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,000
-97.65%
|
$2,025,000
$225.0 P/Share
|
|
Jul 27
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+49.4%
|
$1,251,000
$139.52 P/Share
|
|
Jul 26
2022
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
79,412
-59.25%
|
$17,152,992
$216.3 P/Share
|
|
Jul 26
2022
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
126,000
+48.46%
|
$7,182,000
$57.48 P/Share
|
|
May 11
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-2.44%
|
$35,490
$210.87 P/Share
|
|
May 11
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
363
+4.97%
|
-
|
|
Apr 27
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
144
-39.89%
|
-
|
|
Apr 26
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,000
-94.32%
|
$1,512,000
$252.51 P/Share
|
|
Apr 26
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+48.54%
|
$834,000
$139.52 P/Share
|
|
Apr 26
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,611
-5.86%
|
$407,583
$253.04 P/Share
|
|
Apr 26
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,611
+5.46%
|
$339,921
$211.41 P/Share
|